Patents by Inventor Nicola Schiavone

Nicola Schiavone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Coenzyme Q10 as antiapoptotic agent
    Publication number: 20060127384
    Abstract: The invention discloses the use of coenzyme Q10 for preventing or inhibiting apoptosis in cutaneous or adipose cells and tissues, and pharmaceutical compositions containing coenzyme Q10 for the treatment of transplanted tissues.
    Type: Application
    Filed: December 9, 2004
    Publication date: June 15, 2006
    Inventors: Sergio Capaccioli, Ewa Witort, Domenico Lo Russo, Laura Papucci, Nicola Schiavone, Laura Lapucci, Martino Donnini, Mario Dini, Jacopo Pattarino
  • Use of quinone Q10 for the treatment of ocular diseases
    Patent number: 7029672
    Abstract: The present invention relates to the use of Coenzyme Q10 or functionally equivalent derivatives thereof, through topical or systemic administration, for the prevention, the treatment and/or attenuation of degenerative ocular pathologies, said pathologies being of an heredofamilial, inflammatory, dysmetabolic, senile age-related nature, the degenerative process deriving from apoptotic events caused by hypoxia or other detrimental stimuli due to ischemia or to the lack of trophic factors.
    Type: Grant
    Filed: December 20, 2002
    Date of Patent: April 18, 2006
    Assignee: Giuseppe Simonelli
    Inventors: Rosario Brancato, Giorgio Lenaz, Sergio Capaccioli, Nicola Schiavone
  • Use of ubiquinone Q10 for the local treatment and prevention of post-surgical ophthalmologic pathologies
    Patent number: 6787572
    Abstract: In the treatment of ophthalmologic pathologies in general and in particular in the treatment and prevention of side-effects on eye following photorefractive therapy (PRK), laser-assisted in situ keratomileusis (LASIK) and exposure to solar light and ultraviolet radiation, ubiquinone Q10 is utilized in a collyrium pharmaceutical preparation for ocular topical administration thereof.
    Type: Grant
    Filed: July 9, 2001
    Date of Patent: September 7, 2004
    Inventors: Rosario Brancato, Sergio Capaccioli, Marco Fabrizio Saettone, Nicola Schiavone
  • USE OF UBIQUINONE Q10 FOR THE LOCAL TREATMENT AND PREVENTION OF POST-SURGICAL OPHTHALMOLOGIC PATHOLOGIES
    Publication number: 20030236239
    Abstract: In the treatment of ophthalmologic pathologies in general and in particular in the treatment and prevention of side-effects on eye following photorefractive therapy (PRK), laser-assisted in situ keratomileusis (LASIK) and exposure to solar light and ultraviolet radiation, ubiquinone Q10 is utilized in a collyrium pharmaceutical preparation for ocular topical administration thereof.
    Type: Application
    Filed: July 9, 2001
    Publication date: December 25, 2003
    Applicant: Giuseppe Simonelli
    Inventors: Rosario Brancato, Sergio Capaccioli, Marco Fabrizio Saettone, Nicola Schiavone
  • Use of quinone Q10 for the treatment of ocular diseases
    Publication number: 20030118576
    Abstract: The present invention relates to the use of Coenzyme Q10 or functionally equivalent derivatives thereof, through topical or systemic administration, for the prevention, the treatment and/or attenuation of degenerative ocular pathologies, said pathologies being of an heredofamilial, inflammatory, dysmetabolic, senile age-related nature, the degenerative process deriving from apoptotic events caused by hypoxia or other detrimental stimuli due to ischemia or to the lack of trophic factors.
    Type: Application
    Filed: December 20, 2002
    Publication date: June 26, 2003
    Inventors: Rosario Brancato, Giorgio Lenaz, Sergio Capaccioli, Nicola Schiavone